Market Research Reports Global Selenium Yeast Market Report 2019 | Page 2

The Global Selenium Yeast Market is segmented on the basis of Product Type, End Use Industry and
Region. On the Basis of Product Type segment, the Selenium Yeast Market is sub segmented into Food
Grade, Feed Grade. Based on End Use Industry segment, the Selenium Yeast Market is sub segmented
into Functional Food, Feed Industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by
industry analysts, inputs from industry experts and industry participants across the value chain. The
report provides in-depth analysis of parent market trends, macro-economic indicators and governing
factors along with market attractiveness as per segments. The report also maps the qualitative impact
of various market factors on market segments and geographies.
Some of the major players that operate in the Global Selenium Yeast Market are Alltech, Lesaffre,
Angel, Pharma Nord, Lallemand, Novus International, Associated British foods, Miro Chembiotech,
Cypress Systems, Inc, Diamond V, ADM, Biorigin, Tianxiangyuan.
Latest Industry Updates:
1 Lesaffre:- Whether in breadmaking or in the fields of taste & food pleasure, well -being & health or
biotechnology, Lesaffre has been relying for many years on its fermentation expertise to develop
innovative solutions for its customers. With its state-of-the-art research facilities, the new In Vitro
platform will enable Lesaffre to validate the effectiveness of its existing and future products, develop
new solutions and thus strengthen even more its scientific and technical know-how.
The In Vitro platform, based in the Eurasanté park (Loos, France), is perfectly aligned with Lesaffre’s
commitment to highlight the full potential of microorganisms and fermentation for the nutrition and
health of tomorrow. It completes two Lesaffre research platforms already present in the Eurasanté
park, one platform dedicated to bacteria and the other one to purification and molecules extraction.
2 Pharma NordNow:- A 12-year follow-up analysis of this study, known as the KiSel-10 study, has
shown that senior citizens in the active treatment group have continued to have reduced risk of heart
disease when compared to those study participants who received placebo. The KiSel -10 study was
performed by Professor Urban Alehagen and his research team at the University in Linköping, Sweden.
They enrolled 443 elderly Swedish citizens in the study. Half of the parti cipants received a daily
combination of 200 micrograms of selenium from SelenoPrecise® tablets and 200 milligrams of CoQ10
from Bio-Quinone Active CoQ10 Gold soft-gel capsules. The other half got matching placebo
preparations.
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-
discount/160619 .
Market segment by Regions/Countries, this report covers:
1 North America Country (United States, Canada)
2 South America
3 Asia Country (China, Japan, India, Korea)
4 Europe Country (Germany, UK, France, Italy)